CFXA Stock
Price Chart
CFXA Financial and Trading Overview
stock price | 177.71 |
Previous Close | 180.1 |
Open | 177.18 |
Bid | 0 x 900 |
Ask | 0 x 900 |
Day's Range | 176.83 - 185.61 |
52 Week Range | 153.73 - 212.81 |
Volume | 182.49K |
Avg. Volume | 10.35K |
Market Cap | 4.57B |
Beta (5Y Monthly) | 2.172987 |
PE Ratio (TTM) | 248.89357 |
EPS (TTM) | 0 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
CFXA Valuation Measures
Enterprise Value | 30.94B |
Trailing P/E | 248.89357 |
Forward P/E | N/A |
PEG Ratio (5 yr expected) | N/A |
Price/Sales (ttm) | 1.2499988 |
Price/Book (mrq) | 5.997233 |
Enterprise Value/Revenue | 8.455 |
Enterprise Value/EBITDA | 53.405 |
Trading Information
Stock Price History
Beta (5Y Monthly) | 2.172987 |
52-Week Change | N/A |
S&P500 52-Week Change | N/A |
52 Week High | 212.81 |
52 Week Low | 153.73 |
50-Day Moving Average | 189.08 |
200-Day Moving Average | 189.04 |
CFXA Share Statistics
Avg. Volume (3 month) | 10.35K |
Avg. Daily Volume (10-Days) | 11.84K |
Shares Outstanding | 117.2M |
Float | 137.58M |
Short Ratio | 38.7 |
% Held by Insiders | 0% |
% Held by Institutions | 30.75% |
Shares Short | 41.45K |
Short % of Float | N/A |
Short % of Shares Outstanding | N/A |
Dividends & Splits
Trailing Annual Dividend Rate | N/A |
Trailing Annual Dividend Yield | N/A |
5 Year Average Dividend Yield | N/A |
Payout Ratio | N/A |
Last Split Factor |
Financial Highlights
Fiscal Year
Fiscal Year Ends | December 31, 2020 |
Most Recent Quarter (mrq) | October 1, 2021 |
Next Fiscal Year End | December 31, 2022 |
Profitability
Profit Margin | 2.91% |
Operating Margin (ttm) | 8.78% |
Gross Margin | 42.39% |
EBITDA Margin | 15.83% |
Management Effectiveness
Return on Assets (ttm) | 2.65% |
Return on Equity (ttm) | 3.18% |
Income Statement
Revenue (ttm) | 3.66B |
Revenue Per Share (ttm) | 24.84 |
Quarterly Revenue Growth (yoy) | 19.80% |
Gross Profit (ttm) | N/A |
EBITDA | 579.32M |
Net Income Avi to Common (ttm) | 124.53M |
Diluted EPS (ttm) | 0.714 |
Quarterly Earnings Growth (yoy) | 92.80% |
Balance Sheet
Total Cash (mrq) | 177.48M |
Total Cash Per Share (mrq) | 1.15 |
Total Debt (mrq) | 1.79B |
Total Debt/Equity (mrq) | 38.64 |
Current Ratio (mrq) | 1.769 |
Book Value Per Share (mrq) | 29.632 |
Cash Flow Statement
Operating Cash Flow (ttm) | 388.68M |
Levered Free Cash Flow (ttm) | 210.3M |
Profile of
Country | United States |
State | DE |
City | Wilmington |
Address | 2711 Centerville Road |
ZIP | 19808 |
Phone | 302 252 9160 |
Website | https://www.colfaxcorp.com |
Industry | Specialty Industrial Machinery |
Sector(s) | Industrials |
Full Time Employees | 15400 |
Colfax Corporation operates as a diversified technology company worldwide. The company operates in two segments, Fabrication Technology and Medical Technology. The Fabrication Technology segment formulates, develops, manufactures, and supplies consumable products and equipment, including cutting, joining, and automated welding products, as well as gas control equipment. It also provides welding consumables comprising electrodes, cored and solid wires, and fluxes using a range of specialty and other materials; and cutting consumables, such as electrodes, nozzles, and shields and tips. This segment sells its products through independent distributors and direct sales to the infrastructure, wind power, marine/life sciences, pipelines, mobile/off-highway equipment, oil, gas, and mining markets principally under the ESAB brand. The Medical Technology segment develops, manufactures, and distributes medical device products used by orthopedic specialists, spine surgeons, primary care physicians, pain management specialists, physical therapists, podiatrists, chiropractors, athletic trainers, and other healthcare professionals to treat patients with musculoskeletal conditions resulting from degenerative diseases, deformities, traumatic events, and sports related injuries. It offers rigid and soft orthopedic bracings, hot and cold therapy products, bone growth stimulators, vascular therapy systems and compression garments, therapeutic shoes and inserts, electrical stimulators used for pain management, and physical therapy products; and a suite of reconstructive joint products for the hip, knee, shoulder, elbow, foot, ankle, and finger. This segment sells its products through independent distributors, such as healthcare professionals, consumer retail stores, and pharmacies; and direct and independent distributors under the DJO brand. Colfax Corporation was founded in 1860 and is based in Wilmington, Delaware.
Q&A For Stock
What is a current CFXA stock price?
CFXA stock price today per share is 177.71 .
How to purchase stock?
You can buy CFXA shares on the NYSE exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for ?
The stock symbol or ticker of is CFXA.
Which industry does the company belong to?
The industry is Specialty Industrial Machinery.
How many shares does have in circulation?
The max supply of shares is 0.
What is Price to Earnings Ratio (PE Ratio)?
PE Ratio is now.
What was earnings per share over the trailing 12 months (TTM)?
EPS is 0 over the trailing 12 months.
Which sector does the company belong to?
The sector is Industrials.
CFXA included in indexes
Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
---|
Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
---|---|---|---|---|---|---|---|
{{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
NYSE Composite Index NYA | 20199.49 USD — |
+0.4
|
— — | — — | — — | — - | — — |
- {{ link.label }} {{link}}